2024-03-06 10:01:18 ET
More on Gilead, Merus, etc.
- Gilead Sciences, Inc. (GILD) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)
- Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
- Gilead's business Development: The Good, The Bad, And The Spinning Kite Solution
- Biden to launch task force to target health care costs - report
- Pfizer, Gilead, Roche seen benefitting the most from antibody-drug conjugates
Read the full article on Seeking Alpha
For further details see:
Gilead to invest in Merus as part of a research deal